timeline, page-2

Time is a precious commodity, a commodity that Biota management seem very adept at frittering away.

A very recent example to illustrate this is last night's announcement by Gilead that their liquid (best form to win the pediatric market) based RSV antiviral did very well in Phase 2a trials. 99% reduction in viral loads etc.

Biota were front runners in the RSV race up until a couple of years ago... was part of the reason I hung around for so long...